Cumberland Pharmaceuticals (CPIX) Cash from Operations (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Cash from Operations across 17 years of filings, most recently posting 387025.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 387025.0, down 90.07% year-over-year; the trailing twelve-month figure through Mar 2026 was 1421030.0 (down 73.8% YoY), and the FY2025 annual result was 4932522.0, up 905.72% from the prior year.
• Cash from Operations came in at 387025.0 for Q1 2026 at Cumberland Pharmaceuticals, up from 3024.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 5235361.0 in Q2 2023 to a low of 2136647.0 in Q1 2024.
• The 5-year median for Cash from Operations is 843801.0 (2025), against an average of 1132622.24.
• Across the five-year window, Cash from Operations slumped 842.34% in 2023 and soared 282.46% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Cash from Operations stood at 3638031.0 in 2022, then sank by 71.41% to 1040121.0 in 2023, then jumped by 83.12% to 1904618.0 in 2024, then tumbled by 99.84% to 3024.0 in 2025, then jumped by 12698.45% to 387025.0 in 2026.
• The last three Cash from Operations figures came in at 387025.0 (Q1 2026), 3024.0 (Q4 2025), and 187180.0 (Q3 2025), per Business Quant data.